INSIGHTS ON DRUG DEVELOPMENT

• Evaluating Carryover When Using A TOC Analyzer

  Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

• Data-Driven Strategies To De-Risk OSD Development

  Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

• API Solubility And Dissolution Enhancement Via Formulation

  Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.

• Liberate Your Workflow: Flexible, Multi-Technique Chemical Data Analysis

  Scientific workflows are no longer confined to one device. Cross-platform access to analytical data is becoming essential, helping researchers stay productive and collaborate more effectively.

• Optimize Your mAb Capture And Polishing With The Latest Resins And Tips

  6/26/2025

  Discover the latest innovations in monoclonal antibody purification and explore resin selection strategies to optimize product quality and improve process efficiency.

• Bioprocess Training And Education

  3/17/2026

  Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.

• Working With Clients To Develop Manufacturing Processes

  7/23/2026

  Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, on what it actually looks like when R&D hands a process to the plant — chemists on the floor for the first batch, advising operators and troubleshooting in real time.

• Exosome Production From hMSC Using A Fixed-Bed Bioreactor

  11/3/2025

  Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

• How To Capture Growth In The Expanding Metabolic Drug Market

  12/2/2025

  Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.